IGDB.NSCLC: Integrated genomic database of non-small cell lung cancer

Nucleic Acids Research

Volumn 40, Issue D1, 2012, Pages

  Kao, Sen ^a   Shiau, Cheng Kai ^b   Gu, De Leung ^c   Ho, Chun Ming ^d,e   Su, Wen Hui ^f   Chen, Chian Feng ^c   Lin, Chi Hung ^c   Jou, Yuh Shan ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^e INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; CLINICAL FEATURE; COMPUTER INTERFACE; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DATABASE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR GENE; TUMOR GROWTH; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENES, NEOPLASM; GENETIC VARIATION; GENOMICS; HUMANS; LUNG NEOPLASMS; MICRORNAS; MUTATION; SYSTEMS INTEGRATION;

EID: 84862226123     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr1183     Document Type: Article

References (47)

1. WHO. World Health Organization. "Cancer". http://www.who .int/mediacentre/factsheets/fs297/en/. (3 March 2010, date last accessed).
2. Brose,M.S., Volpe,P., Feldman,M., Kumar,M., Rishi,I., Gerrero,R., Einhorn,E., Herlyn,M., Minna,J., Nicholson,A. et al. (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res., 62, 6997-7000. (Pubitemid 35424092)
3. Lynch,T.J., Bell,D.W., Sordella,R., Gurubhagavatula,S., Okimoto,R.A., Brannigan,B.W., Harris,P.L., Haserlat,S.M., Supko,J.G., Haluska,F.G. et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med., 350, 2129-2139. (Pubitemid 38637993)
4. Ma,P.C., Jagadeeswaran,R., Jagadeesh,S., Tretiakova,M.S., Nallasura,V., Fox,E.A., Hansen,M., Schaefer,E., Naoki,K., Lader,A. et al. (2005) Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res., 65, 1479-1488. (Pubitemid 40270177)
5. Naoki,K., Chen,T.H., Richards,W.G., Sugarbaker,D.J. and Meyerson,M. (2002) Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res., 62, 7001-7003. (Pubitemid 35424093)
6. Paez,J.G., Janne,P.A., Lee,J.C., Tracy,S., Greulich,H., Gabriel,S., Herman,P., Kaye,F.J., Lindeman,N., Boggon,T.J. et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science, 304, 1497-1500. (Pubitemid 38720929)
7. Samuels,Y. and Velculescu,V.E. (2004) Oncogenic mutations of PIK3CA in human cancers. Cell Cycle, 3, 1221-1224. (Pubitemid 40268595)
8. Samuels,Y., Wang,Z., Bardelli,A., Silliman,N., Ptak,J., Szabo,S., Yan,H., Gazdar,A., Powell,S.M., Riggins,G.J. et al. (2004) High frequency of mutations of the PIK3CA gene in human cancers. Science, 304, 554. (Pubitemid 38541907)
9. Sanchez-Cespedes,M., Parrella,P., Esteller,M., Nomoto,S., Trink,B., Engles,J.M., Westra,W.H., Herman,J.G. and Sidransky,D. (2002) Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res., 62, 3659-3662. (Pubitemid 34728843)
10. Santos,E., Martin-Zanca,D., Reddy,E.P., Pierotti,M.A., Della Porta,G. and Barbacid,M. (1984) Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science, 223, 661-664. (Pubitemid 14186799)
11. Stephens,P., Hunter,C., Bignell,G., Edkins,S., Davies,H., Teague,J., Stevens,C., O'Meara,S., Smith,R., Parker,A. et al. (2004) Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature, 431, 525-526.
12. Takahashi,T., Nau,M.M., Chiba,I., Birrer,M.J., Rosenberg,R.K., Vinocour,M., Levitt,M., Pass,H., Gazdar,A.F. and Minna,J.D. (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science, 246, 491-494. (Pubitemid 19273938)
13. Bach,P.B. (2011) Inconsistencies in findings from the early lung cancer action project studies of lung cancer screening. J. Natl. Cancer Inst., 103, 1002-1006.
14. Van't Westeinde,S.C. and van Klaveren,R.J. (2011) Screening and early detection of lung cancer. Cancer J., 17, 3-10.
15. Jemal,A., Siegel,R., Ward,E., Hao,Y., Xu,J. and Thun,M.J. (2009) Cancer statistics, 2009. CA Cancer J. Clin., 59, 225-249.
16. Agullo-Ortuno,M.T., Lopez-Rios,F. and Paz-Ares,L. (2010) Lung cancer genomic signatures. J. Thorac. Oncol., 5, 1673-1691.
17. Risch,A. and Plass,C. (2008) Lung cancer epigenetics and genetics. Int. J. Cancer, 123, 1-7. (Pubitemid 351705185)
18. Chaffer,C.L. and Weinberg,R.A. (2011) A perspective on cancer cell metastasis. Science, 331, 1559-1564.
19. Hanahan,D. and Weinberg,R.A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
20. Sun,S., Schiller,J.H. and Gazdar,A.F. (2007) Lung cancer in never smokers - a different disease. Nat. Rev. Cancer, 7, 778-790. (Pubitemid 47463669)
21. Puissegur,M.P., Mazure,N.M., Bertero,T., Pradelli,L., Grosso,S., Robbe-Sermesant,K., Maurin,T., Lebrigand,K., Cardinaud,B., Hofman,V. et al. (2011) miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ., 18, 465-478.
22. Landi,M.T., Zhao,Y., Rotunno,M., Koshiol,J., Liu,H., Bergen,A.W., Rubagotti,M., Goldstein,A.M., Linnoila,I., Marincola,F.M. et al. (2010) MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res., 16, 430-441.
23. Bass,A.J., Watanabe,H., Mermel,C.H., Yu,S., Perner,S., Verhaak,R.G., Kim,S.Y., Wardwell,L., Tamayo,P., Gat-Viks,I. et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat. Genet., 41, 1238-1242.
24. Boelens,M.C., Kok,K., van der Vlies,P., van der Vries,G., Sietsma,H., Timens,W., Postma,D.S., Groen,H.J. and van den Berg,A. (2009) Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer, 66, 372-378.
25. Broet,P., Camilleri-Broet,S., Zhang,S., Alifano,M., Bangarusamy,D., Battistella,M., Wu,Y., Tuefferd,M., Regnard,J.F., Lim,E. et al. (2009) Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection. Cancer Res., 69, 1055-1062.
26. Ding,L., Getz,G., Wheeler,D.A., Mardis,E.R., McLellan,M.D., Cibulskis,K., Sougnez,C., Greulich,H., Muzny,D.M., Morgan,M.B. et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455, 1069-1075.
27. Shedden,K., Taylor,J.M., Enkemann,S.A., Tsao,M.S., Yeatman,T.J., Gerald,W.L., Eschrich,S., Jurisica,I., Giordano,T.J., Misek,D.E. et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med., 14, 822-827.
28. Weir,B.A., Woo,M.S., Getz,G., Perner,S., Ding,L., Beroukhim,R., Lin,W.M., Province,M.A., Kraja,A., Johnson,L.A. et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature, 450, 893-898. (Pubitemid 350231325)
29. Raponi,M., Zhang,Y., Yu,J., Chen,G., Lee,G., Taylor,J.M., Macdonald,J., Thomas,D., Moskaluk,C., Wang,Y. et al. (2006) Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res., 66, 7466-7472. (Pubitemid 44289200)
30. Takeuchi,T., Tomida,S., Yatabe,Y., Kosaka,T., Osada,H., Yanagisawa,K., Mitsudomi,T. and Takahashi,T. (2006) Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J. Clin. Oncol., 24, 1679-1688. (Pubitemid 46622139)
31. Tseng,R.C., Chang,J.W., Hsien,F.J., Chang,Y.H., Hsiao,C.F., Chen,J.T., Chen,C.Y., Jou,Y.S. and Wang,Y.C. (2005) Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int. J. Cancer, 117, 241-247.
32. Garber,M.E., Troyanskaya,O.G., Schluens,K., Petersen,S., Thaesler,Z., Pacyna-Gengelbach,M., van de Rijn,M., Rosen,G.D., Perou,C.M., Whyte,R.I. et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 98, 13784-13789. (Pubitemid 33115976)
33. Bhattacharjee,A., Richards,W.G., Staunton,J., Li,C., Monti,S., Vasa,P., Ladd,C., Beheshti,J., Bueno,R., Gillette,M. et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA, 98, 13790-13795. (Pubitemid 33115977)
34. Wang,L., Xiong,Y., Sun,Y., Fang,Z., Li,L., Ji,H. and Shi,T. (2010) HLungDB: an integrated database of human lung cancer research. Nucleic Acids Res., 38, D665-D669.
35. Zhu,C.Q., Ding,K., Strumpf,D., Weir,B.A., Meyerson,M., Pennell,N., Thomas,R.K., Naoki,K., Ladd-Acosta,C., Liu,N. et al. (2010) Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J. Clin. Oncol., 28, 4417-4424.
36. Chitale,D., Gong,Y., Taylor,B.S., Broderick,S., Brennan,C., Somwar,R., Golas,B., Wang,L., Motoi,N., Szoke,J. et al. (2009) An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors. Oncogene, 28, 2773-2783.
37. Gautier,L., Cope,L., Bolstad,B.M. and Irizarry,R.A. (2004) affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-315. (Pubitemid 38262761)
38. Tumor Analysis Best Practices Working Group (2004) Expression profiling - best practices for data generation and interpretation in clinical trials. Nat. Rev. Genet, 5, 229-237.
39. Wettenhall,J.M. and Smyth,G.K. (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics, 20, 3705-3706. (Pubitemid 40136823)
40. Li,C. and Wong,W.H. (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA, 98, 31-36. (Pubitemid 32095858)
41. Shiau,C.K., Gu,D.L., Chen,C.F., Lin,C.H. and Jou,Y.S. (2011) IGRhCellID: integrated genomic resources of human cell lines for identification. Nucleic Acids Res., 39, D520-D524.
42. Chen,C.F., Hsu,E.C., Lin,K.T., Tu,P.H., Chang,H.W., Lin,C.H., Chen,Y.J., Gu,D.L., Wu,J.Y., Chen,Y.T. et al. (2010) Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma. Hepatology, 52, 1690-1701.
43. Griffiths-Jones,S., Saini,H.K., van Dongen,S. and Enright,A.J. (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res., 36, D154-D158. (Pubitemid 351149713)
44. Lewis,B.P., Burge,C.B. and Bartel,D.P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20. (Pubitemid 40094598)
45. Krek,A., Grun,D., Poy,M.N., Wolf,R., Rosenberg,L., Epstein,E.J., MacMenamin,P., da Piedade,I., Gunsalus,K.C., Stoffel,M. et al. (2005) Combinatorial microRNA target predictions. Nat. Genet., 37, 495-500. (Pubitemid 40617277)
46. Sethupathy,P., Corda,B. and Hatzigeorgiou,A.G. (2006) TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA, 12, 192-197. (Pubitemid 43121923)
47. Forbes,S.A., Tang,G., Bindal,N., Bamford,S., Dawson,E., Cole,C., Kok,C.Y., Jia,M., Ewing,R., Menzies,A. et al. (2010) COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res., 38, D652-D657.